Pediatrics
Showing 801-900 of 1,596 Results
-
Sandra Soo-Jin Lee, Ph.D
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsDr. Lee is a medical anthropologist whose research focuses on the sociocultural dimensions and ethical issues of emerging technologies and their translation into clinical practice. Dr. Lee leads studies on the public understandings of research using clinical data and biological samples, concepts of race, culture and human genetic variation, and citizen science, commercialization of biotechnology and entrepreneurship.
-
Yunkyeong Lee
Postdoctoral Scholar, Endocrinology and Metabolism
BioYun is a postdoctoral research scholar in the Translational Genomics of Diabetes Laboratory under the mentorship of Dr. Anna Gloyn. Since joining the lab in August 2022, she has been investigating type 2 diabetes (T2D) susceptible genes and their molecular mechanisms in pancreatic β-cell dysfunction and the development of T2D. Her primary focus is on how T2D effector transcripts alter autophagy/mitophagy pathways in human pancreatic β-cells, contributing to β-cell failure, mitochondrial dysfunction, and T2D pathology. She also investigated the impact of genetic mutations underlying neonatal diabetes using CRISPR HDR knockin genome editing in human induced pluripotent stem cell (hiPSC) models and their derivatives.
During her PhD, she explored the role of an epigenetic regulator and its molecular machinery in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), now termed metabolic dysfunction-associated steatotic liver disease (MASLD). In parallel, she studied the interplay between endoplasmic reticulum (ER) stress-mediated unfolded protein response (UPR) signalling and autophagy, and examined how these processes are modulated by bioactive plant extracts in various cellular contexts.
She is particularly interested in exploring inter-organ communication, such as pancreas-liver crosstalk, and how these interactions influence systemic metabolism and contribute to the onset and progression of T2D, along with its complications. Her long-term research goal is to advance our understanding of the cellular and molecular mechanisms driving T2D and to identify novel therapeutic targets and strategies. -
Christopher Lee-Messer, MD, PhD
Clinical Associate Professor, Pediatric Neurology
Clinical Associate Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsMy chief clinical focus is in pediatric epilepsy, especially how epilepsy affects learning and development. For my research, I background in neural development and computational neuroscience towards developing better learning algorithms and applying the latest techniques in machine learning for better diagnosis and treatment of disease.
-
Watinee Leewongjaroen
Administrative Associate 3, Pediatrics - Gastroenterology
Current Role at StanfordAdministrative Associate 3, Pediatrics Gastroenterology.
Faculty academic support for Dr. Ebel, Dr. Narang, Dr. Dike, Dr. Khavari, Dr. Zhang, Dr. Bensen, Dr. Alrabadi, and Dr. Yeh. -
Mary Leonard
Arline and Pete Harman Professor, Professor of Pediatrics (Nephrology), of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.
-
Richard Jonathan Levy
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric) and, by courtesy, of Pediatrics (Cardiology)
BioRichard J. Levy, MD, FAAP is Professor at Stanford University School of Medicine and Chief of Pediatric Cardiac Anesthesiology at Lucile Packard Children’s Hospital. He has been an NIH-funded clinician-scientist for over 20 years. His laboratory currently investigates the toxicity of anesthetics in the developing brain and heart along with mitochondrial mechanisms of anesthesia. He is currently funded to study and develop a benzoquinone molecule as a novel anesthetic. He is an Associate Editor for Frontiers in Pediatrics, Frontiers in Cardiovascular Medicine, and Survey of Anesthesiology and serves as a regular reviewer for Anesthesiology, British Journal of Anaesthesiology, Critical Care Medicine, Anesthesia & Analgesia, Neurotoxicology and Teratology, PLOS One, The Journal of Thoracic and Cardiovascular Surgery, World Journal for Pediatric and Congenital Heart Surgery, and the American Journal of Physiology. In addition, Dr. Levy has served as an ad hoc reviewer for Science, Nature Medicine, Scientific Reports, and Nature Reviews Cardiology.
-
David B. Lewis
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma
Current Research and Scholarly InterestsMy laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.
-
Yungting Liao
Clinical Associate Professor, Pediatrics
Current Research and Scholarly Interestsclinical informatics, quality improvement
-
Andrew Liman, MD
Clinical Assistant Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsPancreatology, Endoscopy, Medical Education
-
Bruce Ling
Senior Research Scientist, Pediatrics - NeonatologyCurrent Research and Scholarly InterestsMy research focuses on developing AI-enabled translational medicine platforms that integrate real-world electronic health records, wearable biosensor signals, LC-MS/MS-based proteomics and metabolomics, cfDNA molecular profiling, and multimodal medical imaging. The overarching goal is to transform longitudinal clinical, physiological, and molecular data into predictive tools for early disease detection, dynamic risk stratification, digital twin modeling, and precision intervention.
-
Michael Link
Lydia J. Lee Professor of Pediatric Cancer
Current Research and Scholarly InterestsHematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.
-
Iris Litt
Marron and Mary Elizabeth Kendrick Professor in Pediatrics, Emerita
Current Research and Scholarly InterestsResearch focus is on the health problems of adolescent women, with particular emphasis on the interaction of psychosocial phenomena with biologic features of the second decade of life. The effects of eating disorders on reproductive physiology, bone density and growth is one example of this interest. Pregnancy prevention and medication compliance in adolescents are other research interests.
-
Jonathan Samuel Litt
Associate Professor of Pediatrics (Neonatal and Developmental Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy research program has two distinct though closely related areas of focus. The first concerns understanding pathways through which chronic health problems impact behavioral development and functional outcomes among preterm infants. I am particularly interested in how neonatal multimorbidity and associated markers of epigenetic aging can help improve risk-prediction for long-term functional outcomes. My second area of academic focus is bringing health services research and improvement science approaches to studying the delivery of high-risk infant follow-up and developing innovative models of post-discharge care. This work includes a focus on population health management, value-based care, and equity-focused quality improvement.
-
Anne Liu
Clinical Professor, Pediatrics - Immunology
Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.
Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.
One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
of broad-spectrum antibiotics.
She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.
For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.
Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.
Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.
Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.
She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health. -
Y. Lucy Liu, MD, PhD
Affiliate, Pediatrics - Hematology/Oncology
BioDr. Liu received her medical and clinical pharmacology training at two of the most prestigious medical institutions in China—West China School of Medicine (Sichuan University) and Peking Union Medical College (PUMC). She possesses extensive research experience in human molecular genetics, tumor biology, and experimental therapeutics.
Dr. Liu is internationally recognized for her expertise in two rare pediatric hematologic disorders: juvenile myelomonocytic leukemia (JMML) and Diamond-Blackfan anemia (DBA). She has authored more than 30 peer-reviewed publications in leading scientific journals, including Nature Genetics, Blood, Leukemia, and the Journal of Clinical Investigation (JCI). At her previous institutions, Dr. Liu served as a Principle Investigator (PI) and co-investigator on several NIH-funded research projects. In 2019, Dr. Liu joined the Department of Pediatrics at the Stanford University School of Medicine as a Senior Research Scientist. She recently developed a novel mouse model for DBA, which has proven to be a valuable tool for evaluating potential therapeutic strategies. Her current research focuses on elucidating the molecular pathogenesis of DBA and developing innovative treatment approaches for DBA. Since joining Stanford, Dr. Liu has published multiple manuscripts highlighting her ongoing research contributions. -
Clara Lo
Clinical Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsResearch interests include:
Biomarkers and targeted therapy in pediatric immune thrombocytopenia
Transfusion-related iron overload
Hemophilia and other rare bleeding disorders
Thrombophilia -
James Lock
Eric Rothenberg, MD Professor and Professor, by courtesy, of Pediatrics
Current Research and Scholarly InterestsJames Lock, MD, Ph.D. is Professor of Child Psychiatry and Pediatrics in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has taught since 1993. He is board certified in adult as well as child and adolescent psychiatry. He directs the eating disorder program in Child Psychiatry and is active in treatment research for children and adolescents with eating disorders.
-
Juanita S. Loftus
Clinical Assistant Professor, Pediatrics - General Pediatrics
BioClinical Focus
____
Pediatrics
Academic Appointment
____
Clinical Assistant Professor, Pediatrics-General Pediatrics
Professional Education
_____
Board Certification: American Board of Pediatrics, Pediatrics (1989)
Residency: St. Louis Children's Hospital, St. Louis, MO (1989)
Medical Education: Washington University School of Medicine, St. Louis, MO (1986) -
Adrienne H. Long, MD, PhD
Instructor, Pediatrics - Hematology & Oncology
BioAdrienne H. Long, MD, PhD is an Instructor and Physician-Scientist in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital, Stanford. Clinically, she completed her MD at Northwestern University, her pediatrics residency at Boston Children’s Hospital, and her oncology fellowship training at Stanford University. Dr. Long sees patients with leukemias/lymphomas, and has a clinical interest in T cell malignancies.
Dr. Long received her PhD in Microbiology/Immunology through a National Institutes of Health (NIH) – Northwestern University partnership, where she worked with Dr. Crystall Mackall to advance CAR T cell therapies. Her influential thesis work was the first to identify T cell exhaustion as a critical factor limiting efficacy of CAR therapies (Long et al., Nature Medicine, 2015). She continued her research training with Dr. Nicholas Haining at the Dana Farber Cancer Institute during residency and is currently conducting her post-doctoral research with Dr. Mark Davis at Stanford.
Dr. Long’s research interests lie at the intersection of the immune system and cancer therapies. She is currently studying how thymic selection, designed to prevent auto-immunity, may also inhibit anti-tumor immunity in children. She is also interested in how immunotherapies that have revolutionized how we treat cancer can impact the developing pediatric immune system long term. -
Anniek Frederike Lubberding
Affiliate, Pediatrics - Endocrinology
BioHuman biologist and (electro-)physiologist bridging cardiac and pancreatic research to improve treatment of diabetes and heart disease.
-
George Lui
Clinical Professor, Medicine - Cardiovascular Medicine
Clinical Professor, Pediatrics - CardiologyCurrent Research and Scholarly InterestsAdult Congenital Heart Disease
-
Angela K. Lumba-Brown
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsCurrent research includes evidence-based guidelines for the management and treatment of traumatic brain injury, research establishing an evidence and targeting treatments for the subtypes of concussion, research identifying the best outcomes in pre-hospital care of patients with traumatic brain injury, research on brain performance via sensorimotor and sensory-cognitive synchronization, and research on dynamic visual synchronization as a biomarker for attentional impairments.
-
Danielle Luz, MD
Affiliate, Department Funds
Fellow in Peds/Clinical InformaticsBioShe is passionate about utilizing health technology to improve the diagnostic odyssey for patients with rare and complex diseases. Her core focus areas include EHR workflow optimization, empowering providers on how to safely utilize AI to generate patient materials to bridge gaps in health literacy, and establishing precision guardrails for the ethical use of AI in genomic medicine.
-
Deirdre J. Lyell, M.D.
Dunlevie Endowed Professor of Maternal-Fetal Medicine and Professor, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPreterm labor prevention and management, preeclampsia prevention and treatment, short and long-term impact of surgical techniques at cesarean, depression during pregnancy, fetal heart rate monitoring and long-term neurologic outcome, randomized clinical trials.
-
David Maahs
Lucile Salter Packard Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health
BioDr David M. Maahs is the Lucile Salter Packard Professor of Pediatrics, Division Chief of Pediatric Endocrinology, and Associate Chair for Academic Affairs in Pediatrics at Stanford University and the Lucile Packard Children’s Hospital. He earned his MD followed by Pediatric Residency at the University of New Mexico. After 3 years on New Mexico’s faculty, Dr. Maahs completed a Pediatric Endocrinology fellowship and a concurrent PhD in Epidemiology at the University of Colorado. He remained on Colorado’s faculty for 10 years, advancing to Professor of Pediatrics before moving to Stanford. Prior to his medical career, Dr. Maahs received a BA and MA in English from the University of Kansas and was inspired to pursue a medical career after serving in the Peace Corps with assignments in Tunisia and the Central African Republic.
Dr. Maahs’ leadership experiences include being a past co-Chair (2013-16) for Protocols and Publications with the Type 1 Diabetes Exchange for which he continues as Director of International Collaborations. This complements his role as President-elect for the International Society of Pediatric and Adolescent Diabetes (ISPAD, 2021-25) and Editor-in-Chief for the 2018 ISPAD Clinical Practice Consensus Guidelines. He served on the Professional Practice Committee for the American Diabetes Association (ADA, 2016-18), which writes the annual ADA Standards of Care. Previously, he served on the ADA Scientific Sessions committee representing the Council on Youth. He has also served on national committees for the American Heart Association, the Pediatric Endocrine Society, and multiple journal editorial boards and review committees.
His scholarly interest is improving care and preventing complications in people with type 1 diabetes (T1D). Along with Dr Peter Chase, he is author of the 12th and 13th editions of Understanding Diabetes, or ‘Pink Panther,’ which are the most widely used educational books for children newly diagnosed with T1D, distributed internationally by the Juvenile Diabetes Research Fund (JDRF). More specifically, he has conducted epidemiologic studies that help generate hypotheses for clinical studies, including trials to develop artificial pancreas systems to improve glucose control, lower disease burden, prevent the complications of diabetes, and reduce disparities in diabetes care. He is author or co-author of over 350 research publications. His multi-disciplinary research has been funded by the JDRF, the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), the Helmsley Charitable Trust, and the National Science Foundation (NSF).
Dr Maahs is Associate Director for the recently formed and NIDDK P30 funded Stanford University Diabetes Research Center (https://sdrc.stanford.edu). His collaborations extend to his role as Principal Investigator (PI) or steering committee member for NIH funded multi-center clinical trials including the FLEX, PERL, and ACTION studies as well as multiple Artificial Pancreas clinical trials. Education, mentorship, and training leadership includes being Program Director with Dr. Georgeanna Klingensmith on the Barbara Davis Center T32 and K12 training grants in Pediatric Endocrinology while at the University of Colorado. He is the PI on the Stanford NIH funded K12 "Training Research Leaders in Type 1 Diabetes.' Dr Maahs is also the Associate Chair for Academic Affairs for the Department of Pediatrics.
While in the Peace Corps, David met his wife, Christine Walravens, who is also a Pediatrician at Stanford. They enjoy outdoor activities and traveling with their adult children. -
Crystal Mackall
Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Current Research and Scholarly InterestsRecent clinical studies, by us and others, have demonstrated that genetically engineered T cells can eradicate cancers resistant to all other therapies. We are identifying new targets for these therapeutics, exploring pathways of resistance to current cell therapies and creating next generation platforms to overcome therapeutic resistance. We have discovered novel insights into the biology of human T cell exhaustion and developed approaches to prevent and reverse this phenomenon.
-
David Magnus, Ph.D.
Thomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor (Teaching) of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsGenetic testing, gene therapy, genetically engineered organisms, and the history of eugenics. Stem cell research and cloning, and egg procurement. Examining ethical issues in reproductive technologies. Organ transplantation including donation after cardiac death, ethics of listing decisions. End of life issues in both adults and children.
-
Sukhada Vaidya Mairal
Clinical Rsch Coord Assoc, Peds/Hospital Medicine
Current Role at StanfordClinical Research Coordinator Associate
-
Yvonne Maldonado
Vice Provost for Faculty Advancement, Taube Professor of Global Health and Infectious Diseases, Professor of Pediatrics (Infectious Diseases) and of Epidemiology and Population Health
Current Research and Scholarly InterestsMy research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.
-
Manasvi Anant Marathe
Administrative Services Administrator 3, Peds/CDCM Center for Definitive and Curative Medicine
BioManasvi Marathe is a Senior Discovery Stage Project Manager at the Center for Definitive and Curative Medicine (CDCM) at Stanford University School of Medicine. In this role, she oversees a diverse portfolio of projects and programs within the genome-editing platform, applying her clinical research expertise and project management acumen to support clinical investigators in achieving their project milestones and goals.
With a foundational career as a dentist in India, she brings a unique perspective to her work, underscored by her commitment to patient care. Her aspiration to impact healthcare on a broader scale led her to pursue a Master’s in Public Health from NYU, marking her transition into clinical research. Throughout her career, she has contributed to a wide array of studies, including epidemiological research, medical device trials, and groundbreaking cell and gene therapies at prestigious institutions such as Harvard T H Chan School of Public Health, NYU Medical School and College of Dentistry, and Stanford University.
Throughout her career, she has demonstrated the ability to lead complex research initiatives and foster collaborations with prominent funding sources like NIH, CIRM, and tech industry leaders such as Apple. -
Peter Margolis, MD, PhD
Adjunct Professor, Pediatrics - General Pediatrics
BioPeter Margolis, MD, PhD, is Adjunct Professor of Pediatrics at Stanford University School of Medicine, Emeritus Professor (pending) of Pediatrics at the University of Cincinnati School of Medicine, and former Co-Director of the James M. Anderson Center for Health Systems Excellence at Cincinnati Children’s Hospital Medical Center. His work encompasses the application and study of systems improvement methods across a broad range of areas, including primary and sub-specialty care, communities, and public health settings to improve the health outcomes of children, families, and communities. Over the last 20 years, he and his research team have developed innovative approaches that engage patients, their families, clinicians, scientists, and communities in developing network-based learning health systems that simultaneously improve care, spawn innovation, and accelerate research. This work has repeatedly demonstrated significant impact on the process and outcomes of care. Dr. Margolis has extensive experience in large-scale comparative effectiveness research, the creation of large-scale interoperable data systems, managing large project teams, and engaging individuals from diverse backgrounds to co-produce improved care and research. He served as Chair of the PCORnet Council, guiding the Patient-Centered Outcomes Research Institute’s investment in transforming research infrastructure in the US. The ImproveCareNow Network, which he leads, was awarded the Drucker Prize, the largest non-profit management and innovation award in the US. Dr. Margolis is an elected member of the National Academy of Medicine.
-
Ivana Maric
Assistant Professor (Research) of Pediatrics (Neonatology)
BioIvana Maric is an Assistant Professor in the Pediatrics Department at the Stanford University School of Medicine. Her research focuses on applying machine learning to improving maternal and neonatal health. Her main focus has been on developing machine learning models for early prediction of adverse outcomes of pregnancy from omics and electronic health records data, that could guide development of low-cost, point of care diagnostic tools. Her main interest is in solutions that are applicable worldwide and especially in low-resource settings. Previously, her research focused on information theory, a mathematical discipline tightly related to statistics and machine learning. She is a recipient of the 2021 Rosenkranz Prize awarded for innovative work to improve health in low- or middle-income countries. She is also a recipient of the 2026 WSPR Best Global Health Abstract Award, 2025 McCormick Faculty Award, the 2025 Reckitt/Mead Johnson Junior Faculty Award from the Western Society for Pediatric Research (WSPR), and the co-recipient of the 2013 IEEE Communications Society Best Tutorial Paper Award. She received BS degree from the University of Novi Sad, Serbia, MS and PhD at Rutgers University and postdoctoral training at Stanford University.
-
Neyssa Marina
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emerita
Current Research and Scholarly InterestsGerm cell tumors and bone sarcomas.
-
John D. Mark
Clinical Professor, Pediatrics - Pulmonary Medicine
BioDr. Mark received his medical degree from the University of Kansas and completed his residency in pediatrics at Children’s Mercy Hospital in Kansas City, Missouri. He then completed a fellowship in pediatric pulmonary medicine at the University of Rochester, Rochester, New York. In 1984, Dr. Mark completed the first fellowship in Pediatric Integrative Medicine at the University of Arizona om 2001. He practices at Packard Children’s Hospital where he utilizes non-pharmaceutical approaches with patients with chronic pulmonary disorders such asthma and cystic fibrosis. He is interested in nutrition, lifestyle changes, exercise and mind/body approaches to healing in an effort to decrease dependence on medication and improve overall lung health.
Dr. Mark is the past Program Director for the Pediatric Pulmonary fellowship program, Co-Director for the Pediatric Integrative Medicine fellowship program and the Medical Director for the Coordinating and Optimizing Resources Effectively (CORE) Program at Packard Children’s Hospital, Stanford University. This innovative program assists with care coordination and communication with all health care providers for children with complex medical needs. Dr. Mark is also the Chair of the Credentials Committee at Packard Children's Hospital.
